PROLIA (DENOSUMAB): ANALYSIS OF RECENT PUBLICATIONS FROM THE AMERICAN SOCIETY FOR BONE AND MINERAL RESEARCH (ASMBR) MEETING 2013
On October 4—7, 2013 Baltimore (USA) hosted the Annual Congress of the American Society for Bone and Mineral Research (ASMBR), during which many publications were devoted to denosumab, a human monoclonal antibody to the main pathogenic link of osteoporosis — RANK-ligand, which results in a dramatic...
Main Author: | E A Pigarova |
---|---|
Format: | Article |
Language: | English |
Published: |
Endocrinology Research Centre
2013-12-01
|
Series: | Остеопороз и остеопатии |
Subjects: | |
Online Access: | https://endojournals.ru/index.php/osteo/article/view/8867 |
Similar Items
-
Experience with denosumab therapy for osteoporosis in rheumatoid arthritis patients receiving glucocorticoids
by: I. S. Dydykina, et al.
Published: (2018-06-01) -
THE INFLUENCE OF INFLIXIMAB THERAPY ON BONE MINERAL DENSITY IN PATIENTS WITH ANKYLOSING SPONDYLITIS
by: T A Raskina, et al.
Published: (2013-12-01) -
Adherence to treatment with denosumab, its efficacy and safety in women with postmenopausal osteoporosis in clinical practice
by: N. V. Toroptsova, et al.
Published: (2016-01-01) -
PRIMENENIE TERIPARATIDA DLYa LEChENIYa TYaZhELOGO OSTEOPOROZA S MNOZhESTVENNYMI PERELOMAMI
by: E A PIGAROVA, et al.
Published: (2014-12-01) -
Treatment of osteoporosis in clinical practice: first experience with the Russian generic drug of zoledronic acid
by: N. V. Toroptsova, et al.
Published: (2022-05-01)